Concepedia

Publication | Open Access

Ixazomib inhibits myeloma cell proliferation by targeting UBE2K

17

Citations

25

References

2021

Year

Abstract

In summary, ixazomib leads to impaired proliferation of myeloma cells by targeting UBE2K.

References

YearCitations

Page 1